Vancouver Infectious Diseases Centre
3 clinical trials · Sponsor
◉ Watch Vancouver Infectious Diseases Centre
| Record | Firm | Date |
|---|---|---|
| Eliminating HCV Infection Among PWUD (NCT05474781) | Vancouver Infectious Diseases Centre | 2019-02-22 |
| Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Marginalized Populations Who Are Virologically Suppressed (NCT04132674) | Vancouver Infectious Diseases Centre | 2018-11-26 |
Track Vancouver Infectious Diseases Centre automatically
Every clearance here is in the API, with alerts when new ones post.